
Koosha Sharifi-tafreshi
Examiner (ID: 427, Phone: (571)270-5897 , Office: P/2623 )
| Most Active Art Unit | 2623 |
| Art Unit(s) | 2623, 2628, 2629, 2695 |
| Total Applications | 1252 |
| Issued Applications | 995 |
| Pending Applications | 71 |
| Abandoned Applications | 217 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16221173
[patent_doc_number] => 20200246289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => FLUORENONE COMPOUND FOR THE TREATMENT OF GOUT
[patent_app_type] => utility
[patent_app_number] => 15/774487
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15774487
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/774487 | Fluorenone compound for the treatment of gout | Nov 10, 2016 | Issued |
Array
(
[id] => 11455886
[patent_doc_number] => 20170049791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 15/347696
[patent_app_country] => US
[patent_app_date] => 2016-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 38742
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347696
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/347696 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | Nov 8, 2016 | Abandoned |
Array
(
[id] => 11497691
[patent_doc_number] => 20170071876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'CYANIDE ANTIDOTE COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/345573
[patent_app_country] => US
[patent_app_date] => 2016-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5691
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15345573
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/345573 | Cyanide antidote compositions and methods of use | Nov 7, 2016 | Issued |
Array
(
[id] => 16236680
[patent_doc_number] => 20200253914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => NOVEL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 15/774420
[patent_app_country] => US
[patent_app_date] => 2016-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15774420
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/774420 | NOVEL FORMULATIONS | Nov 7, 2016 | Abandoned |
Array
(
[id] => 11528537
[patent_doc_number] => 20170088514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'TREATMENT FOR LIPODYSTROPHY'
[patent_app_type] => utility
[patent_app_number] => 15/345035
[patent_app_country] => US
[patent_app_date] => 2016-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7014
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15345035
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/345035 | Treatment for lipodystrophy | Nov 6, 2016 | Issued |
Array
(
[id] => 11755944
[patent_doc_number] => 20170202810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'SMALL MOLECULE INHIBITORS OF USP1 DEUBIQUITINATING ENZYME ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/342175
[patent_app_country] => US
[patent_app_date] => 2016-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26543
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15342175
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/342175 | Small molecule inhibitors of USP1 deubiquitinating enzyme activity | Nov 2, 2016 | Issued |
Array
(
[id] => 13248859
[patent_doc_number] => 10137101
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Alkylamido compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/337707
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 9187
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337707
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337707 | Alkylamido compounds and uses thereof | Oct 27, 2016 | Issued |
Array
(
[id] => 15885281
[patent_doc_number] => 10648977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Angiotensin receptor autoantibodies as biomarker for effected usage of angiotensin receptor blockers
[patent_app_type] => utility
[patent_app_number] => 15/769617
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8080
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769617
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769617 | Angiotensin receptor autoantibodies as biomarker for effected usage of angiotensin receptor blockers | Oct 27, 2016 | Issued |
Array
(
[id] => 16221211
[patent_doc_number] => 20200246327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => QUINOLINE AMIDES AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 15/769914
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769914
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769914 | Quinoline amides and methods of using same | Oct 26, 2016 | Issued |
Array
(
[id] => 16222648
[patent_doc_number] => 20200247764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1
[patent_app_type] => utility
[patent_app_number] => 15/769824
[patent_app_country] => US
[patent_app_date] => 2016-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769824
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769824 | Pharmacophores, compounds and methods having application in the treatment of cancer through inhibition of CYP17A1 and CYP19A1 | Oct 21, 2016 | Issued |
Array
(
[id] => 16222678
[patent_doc_number] => 20200247794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1
[patent_app_type] => utility
[patent_app_number] => 15/769831
[patent_app_country] => US
[patent_app_date] => 2016-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769831 | PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 | Oct 21, 2016 | Abandoned |
Array
(
[id] => 13490009
[patent_doc_number] => 20180296547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => DOSAGE REGIMEN OF MDM2 INHIBITOR FOR TREATING CANCERS
[patent_app_type] => utility
[patent_app_number] => 15/769054
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769054
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769054 | DOSAGE REGIMEN OF MDM2 INHIBITOR FOR TREATING CANCERS | Oct 20, 2016 | Abandoned |
Array
(
[id] => 15974429
[patent_doc_number] => 10667511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Liquid pesticidal composition
[patent_app_type] => utility
[patent_app_number] => 15/769360
[patent_app_country] => US
[patent_app_date] => 2016-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7591
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769360
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769360 | Liquid pesticidal composition | Oct 19, 2016 | Issued |
Array
(
[id] => 16206483
[patent_doc_number] => 20200239473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => NEW DERIVATIVES OF LICOFELONE
[patent_app_type] => utility
[patent_app_number] => 15/769032
[patent_app_country] => US
[patent_app_date] => 2016-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769032
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769032 | NEW DERIVATIVES OF LICOFELONE | Oct 19, 2016 | Abandoned |
Array
(
[id] => 13490017
[patent_doc_number] => 20180296551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/769095
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769095
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769095 | METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES | Oct 18, 2016 | Abandoned |
Array
(
[id] => 11419028
[patent_doc_number] => 20170027173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'INSECTICIDAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/290053
[patent_app_country] => US
[patent_app_date] => 2016-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30372
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15290053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/290053 | INSECTICIDAL COMPOUNDS | Oct 10, 2016 | Abandoned |
Array
(
[id] => 15812767
[patent_doc_number] => 10631539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Fungicidal compositions
[patent_app_type] => utility
[patent_app_number] => 15/767555
[patent_app_country] => US
[patent_app_date] => 2016-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20464
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 702
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767555 | Fungicidal compositions | Oct 9, 2016 | Issued |
Array
(
[id] => 11400452
[patent_doc_number] => 20170020990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'COMPOSITIONS AND METHODS FOR INCREASING INSULIN SENSITIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/284357
[patent_app_country] => US
[patent_app_date] => 2016-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16642
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15284357
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/284357 | COMPOSITIONS AND METHODS FOR INCREASING INSULIN SENSITIVITY | Oct 2, 2016 | Abandoned |
Array
(
[id] => 13925979
[patent_doc_number] => 20190046505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => APREMILAST PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/088801
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088801
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088801 | Apremilast pharmaceutical compositions | Sep 29, 2016 | Issued |
Array
(
[id] => 13476201
[patent_doc_number] => 20180289643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => PHARMACEUTICAL COMPOSITION FOR INDUCING EXERCISE MIMETIC EFFECT
[patent_app_type] => utility
[patent_app_number] => 15/762828
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762828
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762828 | PHARMACEUTICAL COMPOSITION FOR INDUCING EXERCISE MIMETIC EFFECT | Sep 25, 2016 | Abandoned |